Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

52.48
Delayed Data
As of Sep 22
 +0.12 / +0.23%
Today’s Change
45.31
Today|||52-Week Range
75.36
-0.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues106.3M105.3M109.1M108.2M
 
 
 
 
 
Cost of Goods Sold6.6M6.8M7.1M6.9M
 
 
 
 
 
Depreciation And Amortization4.6M4.8M4.8M5.4M
 
 
 
 
 
 
Operating ExpensesGross Income95.1M93.7M97.3M95.8M
 
 
 
 
 
General Expenses127.6M149.5M156.6M155.1M
 
 
 
 
 
Research And Development92.7M108.2M118.2M114.4M
 
 
 
 
 
Total Operating Expenses138.7M161.1M168.4M167.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-32.4M-55.8M-59.3M-59.3M
 
 
 
 
 
Other Expenses0.000.00-672.0K2.9M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.8M-55.1M-60.0M-56.4M
 
 
 
 
 
Net Income-31.8M-55.1M-60.0M-56.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS140.9M141.9M142.5M142.8M
 
 
 
 
 
Shares To Calculate EPS Diluted140.9M141.9M142.5M142.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.39-$0.42-$0.39
 
 
 
 
 
EPS Diluted-$0.23-$0.39-$0.42-$0.39